← back to search

Gregory Michelotti

North Carolina Institute of Medicine ·
Area of research
Cancer Research · Physiology
Research interest
Research interests include Diet and metabolism studies, Cancer, Hypoxia, and Metabolism, Cancer, Lipids, and Metabolism, and Liver Disease Diagnosis and Treatment.
h-index
34
citations
5,202
works
145
NIH funding
primary concept
Biology
email

Recent publications

The Health for Life in Singapore (HELIOS) Study: delivering precision medicine research for Asian populations
Nature Communications 2025cited by 6position: middledoi
Faecal metabolites as a readout of habitual diet capture dietary interactions with the gut microbiome
Nature Communications 2025cited by 4position: middledoi
Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate Cancer
Cancer Research 2024cited by 38position: middledoi
Vitamin A carotenoids, but not retinoids, mediate the impact of a healthy diet on gut microbial diversity
BMC Medicine 2024cited by 16position: middledoi
Machine Learning Metabolomics Profiling of Dietary Interventions from a Six-Week Randomised Trial
Metabolites 2024cited by 8position: middledoi
Genetic and gut microbiome determinants of SCFA circulating and fecal levels, postprandial responses and links to chronic and acute inflammation
Gut Microbes 2023cited by 39position: middledoi
Rare and common genetic determinants of metabolic individuality and their effects on human health
Nature Medicine 2022cited by 154position: middledoi
Serum sphingolipids and incident diabetes in a US population with high diabetes burden: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
American Journal of Clinical Nutrition 2020cited by 44position: middledoi
Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02
Nature Communications 2019cited by 118position: middledoi
Metabolomics Study of the Effects of Inflammation, Hypoxia, and High Glucose on Isolated Human Pancreatic Islets
Journal of Proteome Research 2017cited by 58position: middledoi
TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity
Free Radical Biology and Medicine 2016cited by 38position: middledoi
NAFLD, NASH and liver cancer
Nature Reviews Gastroenterology & Hepatology 2013cited by 961position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Cristina Menni · King's College London3 papers (2024–2025)Kari E. Wong · Metabolon (United States)3 papers (2024–2025)Panayiotis Louca · King's College London3 papers (2024–2025)Ana Nogal · King's College London2 papers (2024–2024)Nicola Segata · Daiichi Sankyo (India)2 papers (2024–2025)Tim D. Spector · US Forest Service2 papers (2024–2025)Mario Falchi · St Thomas' Hospital2 papers (2024–2025)Anna Mae Diehl · Duke University2 papers (2013–2016)Francesco Asnicar · European Institute of Oncology2 papers (2024–2025)Ana M. Valdes · University of Nottingham2 papers (2024–2024)Kate Bermingham · King's College London2 papers (2024–2025)Jonathan Wolf · Defense Health Agency2 papers (2024–2025)Sarah Berry · King's College London2 papers (2024–2025)Alessia Visconti · King's College London2 papers (2024–2025)Qibin Qi · Albert Einstein College of Medicine1 papers (2020–2020)Wolfgang Liedtke · Nippon Paint (Japan)1 papers (2016–2016)Jin Choul Chai · Huazhong Agricultural University1 papers (2020–2020)Alejandro Tamayo‐Garcia · Miami Transplant Institute1 papers (2017–2017)Amrita Vijay · University of Nottingham1 papers (2024–2024)Mariana Verdelho Machado · Champalimaud Foundation1 papers (2013–2013)